This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
February 15, 2021
Targovax receives Fast-Track designation for ONCOS-102
February 12, 2021
Q4 2020 General Market Overview
February 11, 2021
Agenda for Targovax’s Capital Markets Day 18 February 2021
February 10, 2021
BONESUPPORT HOLDING AB – Full Year Report 2020 – invitation to conference call and webcast
February 10, 2021
Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management
February 10, 2021
Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality
February 10, 2021
Vicore Pharma has completed a directed share issue of SEK 336 million
February 09, 2021
Vicore Pharma intends to carry out a directed share issue
February 09, 2021
SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102
February 01, 2021
Positive data from Phase II study ATTRACT in patients with COVID-19 published online